1-1281497-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001130413.4(SCNN1D):c.164C>T(p.Ala55Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000211 in 1,531,100 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001130413.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCNN1D | ENST00000379116.10 | c.164C>T | p.Ala55Val | missense_variant | Exon 3 of 18 | 5 | NM_001130413.4 | ENSP00000368411.5 | ||
SCNN1D | ENST00000379101.8 | n.164C>T | non_coding_transcript_exon_variant | Exon 3 of 17 | 1 | ENSP00000449804.1 | ||||
SCNN1D | ENST00000338555 | c.-235C>T | 5_prime_UTR_variant | Exon 1 of 15 | 2 | ENSP00000339504.2 | ||||
SCNN1D | ENST00000400928 | c.-235C>T | 5_prime_UTR_variant | Exon 2 of 16 | 5 | ENSP00000383717.3 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152178Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.000440 AC: 57AN: 129502Hom.: 1 AF XY: 0.000426 AC XY: 30AN XY: 70412
GnomAD4 exome AF: 0.000202 AC: 278AN: 1378804Hom.: 9 Cov.: 32 AF XY: 0.000194 AC XY: 132AN XY: 680072
GnomAD4 genome AF: 0.000295 AC: 45AN: 152296Hom.: 2 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.164C>T (p.A55V) alteration is located in exon 3 (coding exon 3) of the SCNN1D gene. This alteration results from a C to T substitution at nucleotide position 164, causing the alanine (A) at amino acid position 55 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at